Ian D. Pavord
University of Oxford
667 Papers
5.3K Citations
Ian D. Pavord is an academic researcher from University of Oxford. The author has contributed to research in topics: Asthma & Medicine. The author has an hindex of 108, co-authored 575 publications. Previous affiliations of Ian D. Pavord include John Radcliffe Hospital & University of Warwick.
Chat about Author
Papers
A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma
Dominick E. Shaw,Ruth H. Green,Mike A. Berry,Sarah Mellor,Beverley Hargadon,Maria Shelley,Sue McKenna,Mike Thomas,Ian D. Pavord +8 more
TL;DR: Patients with a diagnosis of asthma have mixed patterns of physiological impairment; many have no airflow obstruction or airway hyper-responsiveness and the physiological characterisation of asthma is not related to symptoms and is of little value in predicting exacerbations or eosinophilic airway inflammation.
47
Air pollution and COPD: GOLD 2023 committee report
Don D. Sin,Dany Doiron,Alvar Agusti,Antonio Anzueto,Peter J. Barnes,Bartolome R. Celli,Gerard J. Criner,David M.G. Halpin,MeiLan K. Han,Fernando J. Martinez,Maria Montes de Oca,Alberto Papi,Ian D. Pavord,N. Roche,Dave Singh,Robert A. Stockley,M. V. Lopez Varlera,Jadwiga A. Wedzicha,Claus Vogelmeier,Jean Bourbeau +19 more
TL;DR: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Scientific Committee performed a comprehensive review on this topic, qualitatively synthesised the evidence to date and proffered recommendations to mitigate the risk as discussed by the authors .
46
Baseline FeNO Independently Predicts the Dupilumab Response in Patients with Moderate-To-Severe Asthma.
Ian D. Pavord,Yamo Deniz,Jonathan Corren,Thomas B. Casale,J. Mark FitzGerald,Kenji Izuhara,Nadia Daizadeh,Benjamin Ortiz,Robert R. Johnson,Sivan Harel,Michel Djandji,Ledia Goga,Nora Crikelair,Paul Rowe,William W. Busse +14 more
TL;DR: In this article , the authors evaluated the value of baseline FeNO, adjusted for baseline blood eosinophil levels and other clinical characteristics, as an independent predictor of treatment response to dupilumab in patients with uncontrolled moderate-to-severe asthma.
46
Lung function and blood levels of copper, selenium, vitamin C and vitamin E in the general population.
Philip Pearson,John Britton,Tricia M. McKeever,Sarah Lewis,Scott T. Weiss,Ian D. Pavord,Andrew W. Fogarty +6 more
TL;DR: Higher levels of serum vitamin C and selenium appear to be associated with higherFEV1, and the association between higher serum copper and lower FEV1 requires further study in view of the ubiquitous exposure to this mineral.
45
Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.
TL;DR: Anti-IL-5 treatment seems generally effective in eosinophilic asthma, either assessed by blood or airway eOSinophilia, and this factor together with the impressive clinical efficacy and good safety profile make anti- IL-5 (mepolizumab, reslizumAB) and benralIZumab (anti-il-5 receptor α) very promising drugs for the treatment of patients with severe eos inophil asthma.
45